Dr. GIULIO TARRO is currently working as a Professor in the Department of Department of Biology, Temple University , USA. His research interests includes human herpesviruses, virus-induced tumour antigens. He is serving as an editorial member and reviewer of several international reputed journals. Dr. GIULIO TARRO is the member of many international affiliations. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to human herpesviruses, virus-induced tumour antigens.
His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the “finger-prints” left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
Dr. Fuhr has 30+ years of experience in teaching and research. He is Professor of Economics at Widener University. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics. He has published over forty journal articles. In health care, he has written on hospital mergers, exclusive arrangements, health insurance, bundling and doctor’s fees. In pharmacoeconomics, Dr. Fuhr has written on cost benefit analysis and predictive modeling. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics.
Magnus S Magnusson, Research Professor. Ph.D. in 1983, University of Copenhagen. Author of the T-pattern model and the corresponding detection algorithms in the T-pattern detection and Analysis software THEMETM (PatternVision.com). He has focused on real-time organisation of behavior, co-directed DNA analysis, published numerous papers and given invited talks and keynotes at universities in Europe, USA and Japan and at international conferences in ethology, psychology, neuroscience, mathematical sciences, science of religion, proteomics and mass spectrometry. Deputy Director 1983-1988 in the Museum of Mankind, National Museum of Natural History, Paris. Repeatedly invited Professor in psychology and ethology (the biology of behavior) at the University of Paris, V, VIII and XIII. Since 1991, Founder and Director of the Human Behavior Laboratory (hbl.hi.is), University of Iceland. He works in collaboration between now 32 universities on Methodology for the Analysis of Social Interaction (MASI) initiated in 1995 at the Sorbonne, Paris based on “Magnusson’s analytical model
Yong-Xi Li has completed his PhD in Beijing Institute of Petroleum Research in China and Postdoctoral training at Cornell University, USA. Currently he is Executive Director at Medpace Bioanalytical Laboratories focusing on bioanalytical analysis, including TK, PK, ADA and Nab method developments, validations and sample analysis for small molecule, polypeptides, protein and antibody therapies. He has published more than 100 papers and one book in reputed journals and publishing house and serving as one of organizers in a biotech conference.
Dr Minaketan Tripathy was born in the village Padmabati, State Odisha, India, in 1978. He obtained his bachelor, master (Pharmaceutics) and doctoral degrees in the field of Pharmacy in the year of 1998, 2001, and 2006 respectively. After serving different institutes in India, Mina served the faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Malaysia, as a senior lecturer from March 2008 till 09thMarch2019.During his long association at UiTM, he established, as well lead the laboratory of Fundamental of Pharmaceutics, attracted many research grants, supervised research students and published several scientific articles in journals of repute and as well conference proceedings. He has been involved in professional contributions as visiting scientist and faculty at different universities. Mina believes in trans-disciplinary research and interdisciplinary linkage. Now that 16th March 2019, Mina joined his new affiliation with a mandate to perform research and academic duties in association with the constituent colleges of Adichunchanagiri University(ACU), in its thriving campus having disciplines of natural sciences, education, engineering, nursing, pharmacy, and medicine.
International Expert in Global Regulatory Affairs; Expert in Biosimilars BioNTech AG
Michel Mikhail has more than 25 years Pharmaceutical Industry experience and track record of achievement in R & D and International Regulatory Affairs in large multinational Research-based pharmaceutical Companies, Biotech Companies as well as in the Generic industry. Dr Mikhail is an Expert in Biosimilars. Has been involved in the Global Development and Worldwide regulatory approval of Blockbuster Medicines He was involved in shaping the EU Biosimilars Guidelines and their Review, the WHO Guidelines, Other ICH Guidelines and now in the US-FDA Biosimilars Guidelines. He is a Chartered Expert in Pharmacology -Toxicology, a chartered Clinical Expert as well as a chartered Analytical Expert. Dr Mikhail served on the Safety working group and Efficacy working Group of the European Federation of pharmaceutical Industry associations (EFPIA) also as a Topic leader. He served on the Regulatory Group of the European branch of the Pharmaceutical Research and Manufacturers of America (PhRMA Europe), on the European Biosimilars Group, the Regulatory and Scientific Affairs Group of the European Generic medicines Association (EGA), as well as on different associations and organizations. Dr Mikhail is member of the Expert committee of the Government Federal Institute of Risk Assessment (BfR) Germany. and served as member of the Expert Committee for Toxicology of the United States Pharmacopoeia
Michel Mikhail’s area of expertise is Non-Clinical Pharmacology and Toxicology as well as Global regulatory Affairs and Regulatory Agencies Interaction. In particular interaction with the US-FDA, the EU_EMA as well as National Agencies in Europe such as UK-MHRA, German BfArM and PEI, France’s ANSM, Sweden’s MPA, among others, interaction with Japan’s PMDA and Emerging markets Agencies. Dr. Michel Mikhail is an Expert in Biosimilars. He is Interested in Immuno-Oncology, Regenerative Medicine, in vitro and in vivo Animal modeling, and mechanisms of Action associated with diseases and regenerative medicine.
Dr. Seema Habib Isa has completed her Ph.D. at the age of 33 years from the Swami Ramanand Teerth Marathwada University, Nanded, Maharashtra, India. Awarded with Honorary Degree of Doctor of Science for outstanding Scientific Contribution in Chemisty by International Agency for standards and Ratings. Awarded the Prestigious Adarsh Saraswati Rashtriya Puraskar by Global Management Council of Glacier Journal Research Foundation, Ahmadabad, Gujarat. She is a Fellow of the International Association of the Science Impact (F.I.A.S.I), published more than 47 papers in reputed journals and has been serving as an Editorial Board Member of the National Journals and International Journals. Her area of research interest is Organic Synthesis and its applications to Inorganic Synthesis.
Organic synthesis and its applications to inorganic compounds: synthesis, Characterization and analytical applications.